Independence Blue Cross, a major insurance company, is no longer covering drugs like Zepbound prescribed solely for weight ...

As the new year kicks up, many people are trying to find ways to stay on top of their weight loss and wellness resolutions.

Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles, cannot seem to shed the pounds hurting their health. “They ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and ...

Robert Machray, a veteran actor known for roles in Cheers as well as numerous other sitcoms and Broadway shows, died at his ...

The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

Veterinary toxicologists are warning clients about the dangers of accidental exposure to semaglutide weight loss medications ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...